Anayancy Ramos Facio
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Anayancy Ramos Facio has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
Christopher S. Sullivan
Department of Molecular Biosciences, The University of Texas at Austin, Austin, USA
1 shared publication- Cristian Voicu Crisan
Department of Pediatrics, Division of Pulmonary, Asthma, Cystic Fibrosis, and Sleep, Emory University School of Medicine, Atlanta, Georgia, USA
1 shared publication Derek Fleming
Department of Surgery, Texas Tech University Health Sciences Center, Lubbock, USA
1 shared publication- Dina A. Moustafa
Department of Pediatrics, Division of Pulmonary, Asthma, Cystic Fibrosis, and Sleep, Emory University School of Medicine
1 shared publication Frances L. Diggle
School of Biological Sciences, Georgia Institute of Technology, Atlanta, USA
1 shared publicationJoanna B. Goldberg
Emory-Children’s Cystic Fibrosis Center, Atlanta, USA
1 shared publication
Latest Publications
- Open Access
- 5 August 2025
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 13 (8) , e0318324
A fluorescence-based protocol to monitor bacterial antagonism
Bacteria are often found in polymicrobial communities where competition for limited space and resources drives antagonistic interactions. Therefore, bacteria have evolved various antibacterial weapons to outcompete their neighbors. These antagonistic interactions can have profound effects on the structure, dynamics, and composition of bacterial communities. To study interactions between two bacterial species, co-culture assays are often employed. The most common approach utilizes selection plates for each bacterial species to quantify recovery after co-incubation. Although this method is relatively accurate and inexpensive, there are some limitations. These assays can be time-consuming, low-throughput, and may present difficulties if the bacteria of interest show similar resistance patterns to one another or if the tolerance to selective agents is unknown. Here, we have developed and validated a method that uses fluorescence as a proxy to screen antibacterial interactions between two species. We utilized two fluorescently tagged bacteria, Staphylococcus aureus JE2 and Escherichia coli DH5⍺, both expressing a red fluorescent protein (RFP), and competed them against non-fluorescent bacteria: two strains of Pseudomonas aeruginosa or one strain of Stenotrophomonas maltophilia . We observed that RFP production correlates with growth in the reporter strains and that a reduction in relative fluorescent units from the reporter strains corresponds with a reduction in colony-forming units. This method is fast, semi-quantitative, semi-high-throughput, and can be used to rapidly screen for antagonistic activity during bacterial co-cultures. We propose that our protocol can be a useful tool to detect antibacterial activity using fluorescently labeled target bacteria. IMPORTANCE: In nature, bacteria often reside in communities where limited space and resources drive competition. Bacterial antagonistic interactions can profoundly affect microbial communities. A common approach to study these interactions is to measure the recovery of each bacterium after competition by using selective media. While relatively accurate and inexpensive, this approach has a few limitations: the assay can be labor-intensive and time-consuming, is low throughput, and can present issues when the bacterial strains of interest have similar antimicrobial resistance or if their resistance profile is unknown. We developed and validated a fast and semi-high-throughput protocol that gauges antagonistic bacterial interactions using fluorescence as a proxy. As proof of principle, this screening protocol was tested with known antagonistic bacteria, using a fluorescently labeled target bacterium.
- 5 August 2025
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 13 (8) , e0318324
Open AccessA fluorescence-based protocol to monitor bacterial antagonism
Bacteria are often found in polymicrobial communities where competition for limited space and resources drives antagonistic interactions. Therefore, bacteria have evolved various antibacterial weapons to outcompete their neighbors. These antagonistic interactions can have profound effects on the structure, dynamics, and composition of bacterial communities. To study interactions between two bacterial species, co-culture assays are often employed. The most common approach utilizes selection plates for each bacterial species to quantify recovery after co-incubation. Although this method is relatively accurate and inexpensive, there are some limitations. These assays can be time-consuming, low-throughput, and may present difficulties if the bacteria of interest show similar resistance patterns to one another or if the tolerance to selective agents is unknown. Here, we have developed and validated a method that uses fluorescence as a proxy to screen antibacterial interactions between two species. We utilized two fluorescently tagged bacteria, Staphylococcus aureus JE2 and Escherichia coli DH5⍺, both expressing a red fluorescent protein (RFP), and competed them against non-fluorescent bacteria: two strains of Pseudomonas aeruginosa or one strain of Stenotrophomonas maltophilia . We observed that RFP production correlates with growth in the reporter strains and that a reduction in relative fluorescent units from the reporter strains corresponds with a reduction in colony-forming units. This method is fast, semi-quantitative, semi-high-throughput, and can be used to rapidly screen for antagonistic activity during bacterial co-cultures. We propose that our protocol can be a useful tool to detect antibacterial activity using fluorescently labeled target bacteria. IMPORTANCE: In nature, bacteria often reside in communities where limited space and resources drive competition. Bacterial antagonistic interactions can profoundly affect microbial communities. A common approach to study these interactions is to measure the recovery of each bacterium after competition by using selective media. While relatively accurate and inexpensive, this approach has a few limitations: the assay can be labor-intensive and time-consuming, is low throughput, and can present issues when the bacterial strains of interest have similar antimicrobial resistance or if their resistance profile is unknown. We developed and validated a fast and semi-high-throughput protocol that gauges antagonistic bacterial interactions using fluorescence as a proxy. As proof of principle, this screening protocol was tested with known antagonistic bacteria, using a fluorescently labeled target bacterium.
- Top Cited PapersOpen Access
- 24 May 2023
- Published by Springer Nature in Nature
- Vol. 618 (7964) , 358-364
A Pseudomonas aeruginosa small RNA regulates chronic and acute infection
The ability to switch between different lifestyles allows bacterial pathogens to thrive in diverse ecological niches1,2. However, a molecular understanding of their lifestyle changes within the human host is lacking. Here, by directly examining bacterial gene expression in human-derived samples, we discover a gene that orchestrates the transition between chronic and acute infection in the opportunistic pathogenPseudomonas aeruginosa. The expression level of this gene, here namedsicX, is the highest of theP. aeruginosagenes expressed in human chronic wound and cystic fibrosis infections, but it is expressed at extremely low levels during standard laboratory growth. We show thatsicXencodes a small RNA that is strongly induced by low-oxygen conditions and post-transcriptionally regulates anaerobic ubiquinone biosynthesis. Deletion ofsicXcausesP. aeruginosato switch from a chronic to an acute lifestyle in multiple mammalian models of infection. Notably,sicXis also a biomarker for this chronic-to-acute transition, as it is the most downregulated gene when a chronic infection is dispersed to cause acute septicaemia. This work solves a decades-old question regarding the molecular basis underlying the chronic-to-acute switch inP. aeruginosaand suggests oxygen as a primary environmental driver of acute lethality.
- 24 May 2023
- Published by Springer Nature in Nature
- Vol. 618 (7964) , 358-364
Top Cited PapersOpen AccessA Pseudomonas aeruginosa small RNA regulates chronic and acute infection
The ability to switch between different lifestyles allows bacterial pathogens to thrive in diverse ecological niches1,2. However, a molecular understanding of their lifestyle changes within the human host is lacking. Here, by directly examining bacterial gene expression in human-derived samples, we discover a gene that orchestrates the transition between chronic and acute infection in the opportunistic pathogenPseudomonas aeruginosa. The expression level of this gene, here namedsicX, is the highest of theP. aeruginosagenes expressed in human chronic wound and cystic fibrosis infections, but it is expressed at extremely low levels during standard laboratory growth. We show thatsicXencodes a small RNA that is strongly induced by low-oxygen conditions and post-transcriptionally regulates anaerobic ubiquinone biosynthesis. Deletion ofsicXcausesP. aeruginosato switch from a chronic to an acute lifestyle in multiple mammalian models of infection. Notably,sicXis also a biomarker for this chronic-to-acute transition, as it is the most downregulated gene when a chronic infection is dispersed to cause acute septicaemia. This work solves a decades-old question regarding the molecular basis underlying the chronic-to-acute switch inP. aeruginosaand suggests oxygen as a primary environmental driver of acute lethality.